The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
NUMB controls p53 tumour suppressor activity
Abstract
NUMB is a cell fate determinant, which, by asymmetrically partitioning at mitosis, controls cell fate choices by antagonising the activity of the plasma membrane receptor of the NOTCH family. NUMB is also an endocytic protein, and the NOTCH-NUMB counteraction has been linked to this function. There might be, however, additional functions of NUMB, as witnessed by its proposed role as a tumour suppressor in breast cancer. Here we describe a previously unknown function for human NUMB as a regulator of tumour protein p53 (also known as TP53). NUMB enters in a tricomplex with p53 and the E3 ubiquitin ligase HDM2 (also known as MDM2), thereby preventing ubiquitination and degradation of p53. This results in increased p53 protein levels and activity, and in regulation of p53-dependent phenotypes. In breast cancers there is frequent loss of NUMB expression. We show that, in primary breast tumour cells, this event causes decreased p53 levels and increased chemoresistance. In breast cancers, loss of NUMB expression causes increased activity of the receptor NOTCH. Thus, in these cancers, a single event-loss of NUMB expression-determines activation of an oncogene (NOTCH) and attenuation of the p53 tumour suppressor pathway. Biologically, this results in an aggressive tumour phenotype, as witnessed by findings that NUMB-defective breast tumours display poor prognosis. Our results uncover a previously unknown tumour suppressor circuitry.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numb inhibits the degradation of p53 by forming the tricomplex of p53 and Hdm2 where it suppresses the ligase activity of Hdm2 [104].”
From Insights of Endocytosis Signaling in Health and Disease (2023) · cites this paper as [104]
In the citing paper
“Furthermore, a remarkable decline in the levels of Numb expression has been observed in approximately 50% of breast cancer [104].”
From Insights of Endocytosis Signaling in Health and Disease (2023) · cites this paper as [104]
In the citing paper
“Endocytic protein Numb governs the level and activity of tumor suppressive protein p53.”
From Insights of Endocytosis Signaling in Health and Disease (2023) · cites this paper as [104]
In the citing paper
“Numb was recently reported to bind and inhibit Mdm2, leading to stabilization of p53, which is consistent with reports of a Numb tumor suppressor function [93].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [93]
In the citing paper
“Numb was recently reported to bind and inhibit Mdm2, leading to stabilization of p53, which is consistent with reports of a Numb tumor suppressor function [93].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [93]
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,911
A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer
Veronesi, U., Paganelli, G., Viale, G., Luini, A., Zurrida, S., Galimberti, V. E., Intra, M., Veronesi, P., Robertson, C., Maisonneuve, P., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa012782 · Cited by 2,204
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Cited by
Sorted by citations
Notch signaling pathway: architecture, disease, and therapeutics
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,216
Notch signaling: simplicity in design, versatility in function
Andersson, E. R., Sandberg, R., & Lendahl, U. (2011) · Development · doi:10.1242/dev.063610 · Cited by 950
Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., Bernard, L., Viale, G., Pelicci, P. G., & Fiore, P. P. D. (2010) · Cell · doi:10.1016/j.cell.2009.12.007 · Cited by 974
Notch signalling in solid tumours: a little bit of everything but not all the time
Ranganathan, P., Weaver, K. L., & Capobianco, A. J. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3035 · Cited by 841
Derailed endocytosis: an emerging feature of cancer
Mosesson, Y., Mills, G. B., & Yarden, Y. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2521 · Cited by 719
The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells
Cicalese, A., Bonizzi, G., Pasi, C. E., Faretta, M., Ronzoni, S., Giulini, B., Brisken, C., Minucci, S., Fiore, P. P. D., & Pelicci, P. G. (2009) · Cell · doi:10.1016/j.cell.2009.06.048 · Cited by 713
Asymmetric cell division: recent developments and their implications for tumour biology
Knoblich, J. A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3010 · Cited by 595
Non-histone protein methylation as a regulator of cellular signalling and function
Biggar, K. K., & Li, S. S.-C. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3915 · Cited by 479
Not(ch) just development: Notch signalling in the adult brain
Ables, J. L., Breunig, J. J., Eisch, A. J., & RAKIC, P. T. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3024 · Cited by 478
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450
Scita, G., & Fiore, P. P. D. (2010) · Nature · doi:10.1038/nature08910 · Cited by 466
Neural stem cells: balancing self-renewal with differentiation
Doe, C. Q. (2008) · Development · doi:10.1242/dev.014977 · Cited by 422
Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancerPreprint
Neumüller, R. A., & Knoblich, J. A. (2009) · Genes & Development · doi:10.1101/gad.1850809 · Cited by 420
Alterations of the Notch pathway in lung cancer
Westhoff, B., Colaluca, I. N., D’Ario, G., Donzelli, M., Tosoni, D., Volorio, S., Pelosi, G., Spaggiari, L., Mazzarol, G., Viale, G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907781106 · Cited by 388
From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
Ntziachristos, P., Lim, J. S., Sage, J., & Aifantis, I. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.018 · Cited by 376
Targeting the MDM2-p53 Interaction for Cancer Therapy
Shangary, S. K., & Wang, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5136 · Cited by 372
Mdm2-mediated ubiquitylation: p53 and beyond
Marine, J.-C., & Lozano, G. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.68 · Cited by 354
Regulation of myeloid leukaemia by the cell-fate determinant Musashi
Ito, T., Kwon, H. Y., Zimdahl, B., Congdon, K. L., Blum, J. M., Lento, W. E., Zhao, C., Lagoo, A. S., Gerrard, G., Foroni, L., et al. (2010) · Nature · doi:10.1038/nature09171 · Cited by 357
Endocytosis and signaling: Cell logistics shape the eukaryotic cell plan
Sigismund, S., Confalonieri, S., Ciliberto, A., Polo, S., Scita, G., & Di Fiore, P. P. (2012) · Physiological Reviews · doi:10.1152/physrev.00005.2011 · Cited by 338
A Phosphoinositide Switch Controls the Maturation and Signaling Properties of APPL Endosomes
Zoncu, R., Perera, R. M., Balkin, D. M., Pirruccello, M., Toomre, D. K., & Camilli, P. V. D. (2009) · Cell · doi:10.1016/j.cell.2009.01.032 · Cited by 347
Epidermal Notch signalling: differentiation, cancer and adhesion
Watt, F. M., Estrach, S., & Ambler, C. A. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.010 · Cited by 294
The Origins and Evolution of the p53 Family of GenesPreprint
Белый, В. А., Ak, P., Markert, E. K., Wang, H., Hu, W., Puzio‐Kuter, A. M., & Levine, A. J. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001198 · Cited by 310
Meng, R. D., Shelton, C. C., Li, Y.-M., Qin, L., Notterman, D. A., Paty, P. B., & Schwartz, G. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2088 · Cited by 287
McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Abrams, S. L., Montalto, G., D’Assoro, A. B., Libra, M., Nicoletti, F., Maestro, R., et al. (2013) · Leukemia · doi:10.1038/leu.2013.184 · Cited by 265
Context-dependent Regulation of the GLI Code in Cancer by HEDGEHOG and Non-HEDGEHOG Signals
Stecca, B. A., & Altaba, A. R. I. (2010) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjp052 · Cited by 253
Cao, J., Xia, L., Wang, T., Zhi, D., Tang, Y., & Li, W. (2020) · Earth-Science Reviews · doi:10.1016/j.earscirev.2020.103091 · Cited by 241
Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
Iglesias, V. S., Giuranno, L., Dubois, L. J., Theys, J., & Vooijs, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00267 · Cited by 233
Reciprocal repression between P53 and TCTP
Amson, R. B., Pece, S., Lespagnol, A., Vyas, R., Mazzarol, G., Tosoni, D., Colaluca, I. N., Viale, G., Rodrigues-Ferreira, S., Wynendaele, J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2546 · Cited by 232
p53-family proteins and their regulators: hubs and spokes in tumor suppression
Collavin, L., Lunardi, A., & Sal, G. D. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.35 · Cited by 225
Polo-like kinase 1 (PLK1) signaling in cancer and beyond
Iliaki, S., Beyaert, R., & Afonina, I. S. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114747 · Cited by 211
The multiple functions of Numb
Gulino, A., Marcotullio, L. D., & Screpanti, I. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.11.017 · Cited by 192
Crosstalk of Notch with p53 and p63 in cancer growth control
Dotto, G. P. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2675 · Cited by 195
The molecular programme of tumour reversion: the steps beyond malignant transformation
Telerman, A., & Amson, R. B. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2589 · Cited by 196
The role of ubiquitin modification in the regulation of p53
Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168
He, Y., Ji, Z., Gong, Y., Fan, L., Xu, P., Chen, X., Miao, J., Zhang, K., Zhang, W., Ma, P., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112033 · Cited by 160
Asymmetric cell division of stem and progenitor cells during homeostasis and cancer
Gómez‐López, S., Lerner, R. G., & Petritsch, C. K. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1386-1 · Cited by 159
p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome
Spike, B. T., & Wahl, G. M. (2011) · Genes & Cancer · doi:10.1177/1947601911410224 · Cited by 160
Memo Is a Copper-Dependent Redox Protein with an Essential Role in Migration and Metastasis
MacDonald, G., Nalvarte, I., Смирнова, Т. А., Vecchi, M., Aceto, N., Doelemeyer, A., Frei, A., Lienhard, S., Wyckoff, J. B., Heß, D., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004870 · Cited by 149
Hedgehog signalling in breast cancer
Kasper, M., Jaks, V., Fiaschi, M., & Toftgård, R. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp048 · Cited by 153
NUMB-ing down cancer by more than just a NOTCH
Pece, S., Confalonieri, S., Romano, P. R., & Fiore, P. P. D. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.001 · Cited by 146
Methylation multiplicity and its clinical values in cancer
Dai, X., Ren, T., Zhang, Y., & Nan, N. (2021) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.4 · Cited by 150
Kiyokawa, H., & Morimoto, M. (2019) · Development Growth & Differentiation · doi:10.1111/dgd.12628 · Cited by 133
Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
Ou, S., Wang, H., Tao, Y., Luo, K., Ye, J., Ran, S., Guan, Z., Wang, Y., Hu, H., & Huang, R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1020583 · Cited by 139
Hung, P.-S., Liu, C., Chou, C.-S., Kao, S., Yang, C., Chang, K., Chiu, T.-H., & Lin, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079926 · Cited by 128
The cytoplasmic side of p53's oncosuppressive activities
Comel, A., Sorrentino, G., Capaci, V., & Sal, G. D. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.015 · Cited by 130
Endocytosis and Cancer: an ‘Insider’ Network with Dangerous Liaisons
Lanzetti, L., & Di Fiore, P. P. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00816.x · Cited by 119
Kusko, R. L., Brothers, J. F., Tedrow, J. R., Pandit, K. V., Huleihel, L., Perdomo, C., Liu, G., Juan-Guardela, B. M., Kass, D. J., Zhang, S., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2026oc · Cited by 118
Notch Signalling in Breast Development and Cancer
Edwards, A., & Brennan, K. R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.692173 · Cited by 116
Dynamic Methylation of Numb by Set8 Regulates Its Binding to p53 and Apoptosis
Dhami, G. K., Liu, H., Galka, M., Voss, C., Wei, R., Muranko, K., Kaneko, T., Cregan, S. P., Li, L., & Li, S. S. ‐. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.04.028 · Cited by 123
Numb regulates cell–cell adhesion and polarity in response to tyrosine kinase signalling
Wang, Z., Sandiford, S. D. E., Wu, C., & Li, S. S. ‐. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.190 · Cited by 121
TPT1/ TCTP-regulated pathways in phenotypic reprogramming
Amson, R. B., Pece, S., Marine, J., Fiore, P. P. D., & Telerman, A. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.10.002 · Cited by 121
Advancing a clinically relevant perspective of the clonal nature of cancer
Ruiz, C. F., Lenkiewicz, E., Evers, L., Holley, T., Robeson, A., Kiefer, J., Demeure, M. J., Hollingsworth, M. A., Shen, M., Prunkard, D. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104009108 · Cited by 111
Novel Dyskerin-Mediated Mechanism of p53 Inactivation through Defective mRNA Translation
Montanaro, L., Calienni, M., Bertoni, S., Rocchi, L., Sansone, P., Storci, G., Santini, D., Ceccarelli, C., Taffurelli, M., Carnicelli, D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4024 · Cited by 126
Notch signalling in cancer stem cells
Bolós, V., Blanco, M., Médina, V., Aparicio, G., Díaz‐Prado, S., & Grande, E. (2009) · Clinical & Translational Oncology · doi:10.1007/s12094-009-0305-2 · Cited by 110
NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer
Belle, V. A., McDermott, N., Meunier, A., & Marignol, L. H. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.195 · Cited by 108
Numb controls E-cadherin endocytosis through p120 catenin with aPKC
Sato, K., Watanabe, T., Wang, S., Kakeno, M., Matsuzawa, K., Matsui, T., Yokoi, K., Murase, K., Sugiyama, I., Ozawa, M., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-03-0274 · Cited by 105
Li, P., Fu, Z.-Y., Zhang, Y., Zhang, J., Xu, C., Ma, Y.-T., Li, B.-L., & Song, B. (2013) · Nature Medicine · doi:10.1038/nm.3417 · Cited by 106
β-TrCP-Mediated Ubiquitination and Degradation of PHLPP1 Are Negatively Regulated by Akt
Li, X., Liu, J., & Gao, T. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00681-09 · Cited by 99
Orr, B., & Compton, D. A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00164 · Cited by 109
Teng, T., Mercer, C. A., Hexley, P., Thomas, G., & Fumagalli, S. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01174-13 · Cited by 98
microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review
Makowska, M., Smolarz, B., & Romanowicz, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043521 · Cited by 97
Aberrant regulation of FBW7 in cancer
Wang, L., Ye, X., Liu, Y., Wei, W., & Wang, Z. P. (2014) · Oncotarget · doi:10.18632/oncotarget.1859 · Cited by 91
Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells
Rasul, S., Balasubramanian, R., Filipović, A., Slade, M. J., Yagüe, E., & Coombes, R. C. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605034 · Cited by 88
Santoro, A., Vlachou, T., Luzi, L., Melloni, G. E. M., Mazzarella, L., D’Elia, E., Xieraili, A., Pasi, C. E., Reavie, L. B., Bonetti, P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.071 · Cited by 88
Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF–triggered granulopoiesis
Skokowa, J., Klimiankou, M., Klimenkova, O., Lan, D., Gupta, K., Hussein, K., Carrizosa, E., Kusnetsova, I., Li, Z., Sustmann, C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2958 · Cited by 88
Dang, T. P. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_15 · Cited by 87
Abreu, R. D. S., Sánchez-Díaz, P. C., Vogel, C., Burns, S. C., Ko, D., Burton, T. L., Vo, D. T., Chennasamudaram, S., Le, S., Shapiro, B. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809605200 · Cited by 87
Liu, Z., Li, H., Su, J., Xu, S., Zhu, F., Ai, J., Hu, Z. M., Zhou, M., Tian, J., Su, Z., et al. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7432 · Cited by 81
Vo, D. T., Subramaniam, D., Remke, M., Burton, T. L., Uren, P. J., Gelfond, J. A. L., Abreu, R. D. S., Burns, S. C., Qiao, M., Suresh, U., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.07.031 · Cited by 86
Numb is required to prevent p53-dependent senescence following skeletal muscle injury
Le Roux, I., Konge, J., Le Cam, L., Flamant, P., & Tajbakhsh, S. (2015) · Nature Communications · doi:10.1038/ncomms9528 · Cited by 81
Afshar, Y., Miele, L., & Fazleabas, A. T. (2012) · Endocrinology · doi:10.1210/en.2011-2122 · Cited by 82
Bélanger, M.-C., Robert, B., & Cayouette, M. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.11.020 · Cited by 82
Notch Signaling and Breast Cancer
Reedijk, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_18 · Cited by 83
García-Heredia, J. M., Lucena-Cacace, A., Verdugo‐Sivianes, E. M., Pérez, M., & Carnero, A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2358 · Cited by 81
Voutsadakis, I. A. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-67 · Cited by 86
Gödde, N., Galea, R. C., Elsum, I. A., & Humbert, P. O. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9180-2 · Cited by 85
Molecular Oncology of Breast Cancer
Joshi, H. N., & Press, M. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00022-2 · Cited by 85
Molecular mechanisms of asymmetric divisions in mammary stem cells
Santoro, A., Vlachou, T., Carminati, M., Pelicci, P. G., & Mapelli, M. (2016) · EMBO Reports · doi:10.15252/embr.201643021 · Cited by 81
Liu, H., Du, J., Chao, S., Li, S., Cai, H., Zhang, H., Chen, G., Liu, P., & Bu, P. (2022) · Advanced Science · doi:10.1002/advs.202105222 · Cited by 73
Cancer Stemness: p53 at the Wheel
Ghatak, D., Ghosh, D. D., & Roychoudhury, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.604124 · Cited by 75
Rennstam, K., McMichael, N., Berglund, P., Honeth, G., Hegardt, C., Rydén, L., Luts, L., Bendahl, P., & Hedenfalk, I. A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0568-x · Cited by 75
Targeting the MDM2-p53 protein–protein interaction for new cancer therapeutics
Wang, S., Zhao, Y., Bernard, D., Aguilar, A., & Kumar, S. (2012) · Topics in Medicinal Chemistry · doi:10.1007/978-3-642-28965-1_2 · Cited by 72
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD Risk Locus 19q13.2
Ryan, D. M., Vincent, T. L., Salit, J., Walters, M. S., Agosto-Perez, F., Shaykhiev, R., Strulovici‐Barel, Y., Downey, R. J., Buro-Auriemma, L. J., Staudt, M. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088051 · Cited by 72
Regulation of the p53 pathway by ubiquitin and related proteins
Hock, A., & Vousden, K. H. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.06.011 · Cited by 70
Peng, H., Wang, L., Su, Q., Yi, K., Du, J., & Wang, Z. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.048 · Cited by 68
E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma
Bielskienė, K., Bagdonienė, L., Mozūraitienė, J., Kazbarienė, B., & Janulionis, E. (2015) · Medicina · doi:10.1016/j.medici.2015.01.007 · Cited by 67
Siddique, H. R., Feldman, D. E., Chen, C., Punj, V., Tokumitsu, H., & Machida, K. (2015) · Hepatology · doi:10.1002/hep.27987 · Cited by 67
Tosoni, D., Zecchini, S., Coazzoli, M., Colaluca, I. N., Mazzarol, G., Rubio, A., Caccia, M., Villa, C. E., Zilian, O., Fiore, P. P. D., et al. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201505037 · Cited by 68
Zhang, J., Shao, X., Sun, H., Liu, K., Ding, Z., Chen, J., Fang, L., Su, W., Hong, Y., Li, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11062 · Cited by 67
Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy
Sánchez-Díaz, P. C., Burton, T. L., Burns, S. C., Hung, J. Y., & Penalva, L. O. F. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-280 · Cited by 66
Nagano-Ito, M., & Ichikawa, S. (2012) · Biochemistry Research International · doi:10.1155/2012/204960 · Cited by 65
Moving Breast Cancer Therapy up a Notch
Mollen, E., Ient, J., Tjan‐Heijnen, V. C. G., Boersma, L. J., Miele, L., Smidt, M. L., & Vooijs, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00518 · Cited by 67
Puca, F., Colamaio, M., Federico, A., Gemei, M., Tosti, N., Bastos, A. U., Vecchio, L. D., Pece, S., Battista, S., & Fusco, A. (2014) · Oncotarget · doi:10.18632/oncotarget.1914 · Cited by 65
hSSB1 regulates both the stability and the transcriptional activity of p53
Xu, S., Wu, Y., Chen, Q., Cao, J., Hu, K., Tang, J., Sang, Y., Lai, F., Wang, L., Zhang, R., et al. (2012) · Cell Research · doi:10.1038/cr.2012.162 · Cited by 68
Jiang, X., Xing, H., Kim, T., Jung, Y., Huang, W., Yang, H. W., Song, S., Park, P. J., Carroll, R. S., & Johnson, M. D. (2012) · Stem Cells · doi:10.1002/stem.1120 · Cited by 65
Sheng, W., Dong, M., Chen, C., Wang, Z., Li, Y., Wang, K., Li, Y., & Zhou, J. (2017) · The FASEB Journal · doi:10.1096/fj.201601240r · Cited by 64
The New Faces of Endocytosis in Signaling
Hupalowska, A., & Miączyńska, M. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01249.x · Cited by 61
Numb family proteins are essential for cardiac morphogenesis and progenitor differentiation
Zhao, C., Guo, H., Li, J., Myint, T., Pittman, W., Yang, L., Zhong, W., Schwartz, R. J., Schwarz, J. J., Singer, H. A., et al. (2013) · Development · doi:10.1242/dev.093690 · Cited by 59
Insights of Endocytosis Signaling in Health and Disease
Pathak, C., Vaidya, F. U., Waghela, B. N., Jaiswara, P. K., Gupta, V. K., Kumar, A., Rajendran, B. K., & Ranjan, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032971 · Cited by 59
Fearful Symmetry: Subversion of Asymmetric Division in Cancer Development and Progression
Bajaj, J., Zimdahl, B., & Reya, T. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2750 · Cited by 63
Metadata
- Authors
- Colaluca, I. N., Tosoni, D., Nuciforo, P., Senic-Matuglia, F., Galimberti, V., Viale, G., Pece, S., & Di Fiore, P. P.
- Affiliations
- IFOM (IT)
- European Institute of Oncology (IT)
- University of Milan (IT)
- Corresponding author
- Pece, Salvatore
- ORCID
- Venue
- Nature
- Published
- 2008-01
- Volume
- 451
- Issue
- 7174
- Pages
- 76-80
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2072555538
- Cited by
- 385
- References
- 33
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 9 · 2023: 25 · 2022: 19 · 2021: 19 · 2020: 15 · 2019: 12 · 2018: 18 · 2017: 19 · 2016: 22 · 2015: 22 · 2014: 27 · 2013: 25 · 2012: 36
- FWCI
- 18.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Fondazione Cariplo
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Numb, p53, MDM2, tumour suppressor, breast cancer, Notch receptor, ubiquitination, protein stability, chemoresistance, prognosis, asymmetric cell division, endocytosis, oncogene activation
- MeSH terms
- Breast Neoplasms, Cells, Cultured, DNA Damage, Humans, Membrane Proteins, Nerve Tissue Proteins, Prognosis, Protein Binding, Tumor Suppressor Protein p53, Drug Resistance, Neoplasm, Gene Silencing, Cell Line, Tumor, Proto-Oncogene Proteins c-mdm2, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
